Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Aug 14, 2026

SGMOQ — SANGAMO THERAPEUTICS, INC Dilution Risk Tracker

Track SGMOQ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SGMOQ — Get alerts when the score changes →

As of August 14, 2026, SANGAMO THERAPEUTICS, INC (SGMOQ) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. SANGAMO THERAPEUTICS, INC has 414.29M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
65
📊Float Risk
⚠️ Warrant Exposure
15
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
7%
💰 Capital Raise 15%
• Under 12 months cash (9mo)
🔔 Track SGMOQ — Get forecast alerts →

Market Data

Market CapN/A
Shares Outstanding414.29M
FloatN/A
Cash$121.97M
DebtN/A
Short InterestN/A

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest10.34M
Days to Cover2.3
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track SGMOQ Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SGMOQ — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations